Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Cost of RevenueCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2021: $1.06M2022: $13.7K2023: $116.1K2024: $347.0K2025: $484.6K$484.6K2021Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$484.6K+39.7%2024$347.0K+198.8%2023$116.1K+744.9%2022$13.7K-98.7%2021$1.06M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share